Navigation Links
BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
Date:4/5/2011

RALEIGH, N.C., April 5, 2011 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today completion of enrollment in its Phase 3 clinical trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain.

(Logo: https://photos.prnewswire.com/prnh/20110217/CL49801LOGO)

"The completion of enrollment in our Phase 3 efficacy study marks another very important milestone in our clinical development program for BEMA Buprenorphine in the management of chronic pain," stated Dr. Andrew Finn, Executive Vice President of Product Development at BDSI.  "We are very pleased to have achieved our aggressive recruitment and enrollment goals.  This milestone keeps us on target for reporting top-line study results in the third quarter of this year and is consistent with a timeline that would allow for a New Drug Application (NDA) to be filed in the second quarter of 2012."

BDSI believes that there remains a significant unmet medical need for potent new analgesics for the treatment of chronic pain.  The company believes that buprenorphine is an attractive option for development because of its potent analgesic properties, its differentiating characteristics from other opioids and its DEA Schedule III designation, which means there is less addiction potential than Schedule II products.  In addition, BEMA Buprenorphine has the potential to be the first oral transmucosal form of buprenorphine to treat chronic pain in the U.S.  According to Wolters Kluwer, opioid analgesic sales in the U.S. are in excess of $10 billion and growing, and BDSI believes that BEMA Buprenorphine has the potential to exceed $500 million in peak annual sales.

Additional Information on Phase 3 Study Design (BUP-301)

This Phase 3 trial of BEMA Buprenorphine (referred to as BUP-301) is
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
2. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
3. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
4. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
5. TCG Lifesciences Expands Pharmaceutical, Biotechnology Research Initiatives with CAS SciFinder®
6. Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology
7. Caliper Life Sciences Launches Novel COX-2 Probe to Enable Personalized Medicine Research
8. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
9. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
10. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
11. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced ... older adults suffering from the severe cold weather that has ... committed to helping those in need; so to support these ... contributions up to $250,000, which could mean up to $500,000 ...
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... , LAKE FOREST, Ill., Oct. 27 Hospira, Inc. ... and medication delivery company, today reported results for the ... the quarter were $1.0 billion, and adjusted* diluted earnings ... items as described later in this press release and ...
... today announced $4.5 million in Series A and Convertible Note ... company,s ongoing Phase I/IIa trial of BP-GMAX-CD1 in patients with ... IIb trials. The company anticipates reporting initial results of the ... brings the total raised to date to $8.5 million, including ...
Cached Medicine Technology:Hospira Reports Third-Quarter 2009 Results 2Hospira Reports Third-Quarter 2009 Results 3Hospira Reports Third-Quarter 2009 Results 4Hospira Reports Third-Quarter 2009 Results 5Hospira Reports Third-Quarter 2009 Results 6Hospira Reports Third-Quarter 2009 Results 7Hospira Reports Third-Quarter 2009 Results 8Hospira Reports Third-Quarter 2009 Results 9Hospira Reports Third-Quarter 2009 Results 10Hospira Reports Third-Quarter 2009 Results 11Hospira Reports Third-Quarter 2009 Results 12Hospira Reports Third-Quarter 2009 Results 13Hospira Reports Third-Quarter 2009 Results 14Hospira Reports Third-Quarter 2009 Results 15Hospira Reports Third-Quarter 2009 Results 16Hospira Reports Third-Quarter 2009 Results 17Hospira Reports Third-Quarter 2009 Results 18Hospira Reports Third-Quarter 2009 Results 19Hospira Reports Third-Quarter 2009 Results 20Hospira Reports Third-Quarter 2009 Results 21Hospira Reports Third-Quarter 2009 Results 22Hospira Reports Third-Quarter 2009 Results 23Hospira Reports Third-Quarter 2009 Results 24Hospira Reports Third-Quarter 2009 Results 25Hospira Reports Third-Quarter 2009 Results 26Hospira Reports Third-Quarter 2009 Results 27Hospira Reports Third-Quarter 2009 Results 28Bellicum Pharmaceuticals Announces $4.5 Million in New Funding 2
(Date:4/23/2014)... have shown that proliferation of endogenous neural precursor ... neurons and axons. From the perspective of neural ... Yat-sen University in China observed the effects of ... cell proliferation and expression of basic fibroblast growth ... brain on the infarct side. The researchers found ...
(Date:4/22/2014)... the New Jersey Institute of Technology (NJIT) today ... the launch of the New Jersey Innovation Institute ... model for business innovation through the leveraging of ... U.S. Senator Cory Booker, Panasonic Corp. of North ... Lieutenant Governor Kim Guadagno, New Jersey Secretary of ...
(Date:4/22/2014)... clinics that can provide primary care for low-income ... hospitals and insurance companies while improving patient health, ... admissions suggests that health clinics that avoid costs ... money by lowering hospital admission rates and emergency ... economics, Penn State Altoona. , The researchers ...
(Date:4/22/2014)... women using a newer method of planned sterilization called ... a 10-year period than using the more commonly performed ... and UC Davis has found. , Published online ... study found the higher risk of pregnancy with a ... , "This study provides essential information for women ...
(Date:4/22/2014)... scientists have found a way to block abnormal cholesterol ... atherosclerosis, the main cause of heart attacks and strokes ... condition develops when fat builds inside blood vessels over ... reducing their ability to feed oxygen-rich blood to the ... of experiments, described April 7 in the journal ...
Breaking Medicine News(10 mins):Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Clinics not bogged down by red tape can ease health cost burdens 2Health News:Risk of pregnancy greater with newer method of female sterilization 2Health News:Risk of pregnancy greater with newer method of female sterilization 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4
... undergoing treatment for breast cancer can experience cognitive declines, ... and attention. Often experienced by patients undergoing chemotherapy, the ... health psychologist at the University of Missouri says "chemo ... associate professor and chair of the Health Psychology Department ...
... , WEDNESDAY, April 11 (HealthDay News) -- ... people in the United States who lived in state-regulated ... federal report. People who live in residential care ... supportive services because they can,t live independently but generally ...
... , WEDNESDAY, April 11 (HealthDay News) -- Being ... a new study that found that genes are at least ... generous. Researchers at the University at Buffalo and the ... different versions of receptor genes for two hormones -- oxytocin ...
... Sciences Discovery Fund (LSDF) today announced nearly $450,000 ... foster commercial translation of new health and health-care ... disease. Dr. Philip Fleckman at the University of ... material for reducing infections associated with kidney dialysis ...
... pacemakers have set the rhythm for many hearts. ... by leaps and bounds: they have become ever-smaller ... toward miniaturized, intelligent systems that will take over ... future implantable sensors will measure glucose levels, blood ...
... Nursing for Women,s Health highlights the importance of a ... contraception is a means of health promotion and women who ... healthy prior to conceiving can minimize their risk of complications ... Disease Control and Prevention (CDC) there were more than four ...
Cached Medicine News:Health News:Stress contributes to cognitive declines in women with breast cancer, researcher says 2Health News: Some Folks Just Can't Help Being Nice, Study Suggests 2Health News:Washington's Life Sciences Discovery Fund awards commercialization grants 2Health News:Power without the cord 2Health News:Power without the cord 3Health News:Timing pregnancy an important health concern for women 2
... iCycler iQ real-time PCR detection system is ... into place directly above the thermal cycler. ... wavelengths available, facilitating the greatest array of ... of the iCycler iQ system, the iCycler ...
Chemically Resistant Sealing Mat for 96ch, 1.1ml or 2.0ml, Deep Well, Round Available Sterile...
Sealing Mat for 384-well, Square Well Plates Available Sterile...
Silicone Compression Mat, Bulk...
Medicine Products: